메뉴 건너뛰기




Volumn 11, Issue 12, 2015, Pages 2211-2222

Mechanism of nanotization-mediated improvement in the efficacy of caffeine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Caffeine; Caffeine encapsulated PLGA nanoparticles; Parkinson's disease

Indexed keywords

AMINO ACIDS; BIOCHEMISTRY; CHEMICAL ACTIVATION; ENZYMES; MAMMALS; METABOLITES; NANOPARTICLES; NEURODEGENERATIVE DISEASES; NEURONS; PHOSPHORYLATION;

EID: 84953343670     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2015.2107     Document Type: Article
Times cited : (10)

References (37)
  • 1
    • 77951648520 scopus 로고    scopus 로고
    • Proteomics in Parkinson's disease: Current trends, translational snags and future possibilities
    • G. Srivastava, K. Singh, M. N. Tiwari, and M. P. Singh, Proteomics in Parkinson's disease: Current trends, translational snags and future possibilities. Expert Rev. Proteomics 7, 127 (2010).
    • (2010) Expert Rev. Proteomics , vol.7 , pp. 127
    • Srivastava, G.1    Singh, K.2    Tiwari, M.N.3    Singh, M.P.4
  • 2
    • 33749184503 scopus 로고    scopus 로고
    • Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease
    • M. P. Singh, S. Patel, M. Dikshit, and Y. K. Gupta, Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease. Indian J. Biochem. Biophys. 43, 69 (2006).
    • (2006) Indian J. Biochem. Biophys. , vol.43 , pp. 69
    • Singh, M.P.1    Patel, S.2    Dikshit, M.3    Gupta, Y.K.4
  • 3
    • 84856721686 scopus 로고    scopus 로고
    • Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: Is it all set to irrefutable clinical translation
    • N. K. Singhal, G. Srivastava, S. Agrawal, S. K. Jain, and M. P. Singh, Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: Is it all set to irrefutable clinical translation. Mol. Neurobiol. 45, 186 (2012).
    • (2012) Mol. Neurobiol. , vol.45 , pp. 186
    • Singhal, N.K.1    Srivastava, G.2    Agrawal, S.3    Jain, S.K.4    Singh, M.P.5
  • 4
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • W. Dauer and S. Przedborski, Parkinson's disease: Mechanisms and models. Neuron 39, 889 (2003).
    • (2003) Neuron , vol.39 , pp. 889
    • Dauer, W.1    Przedborski, S.2
  • 5
    • 84877328104 scopus 로고    scopus 로고
    • Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease
    • A. Dixit, G. Srivastava, D. Verma, M. Mishra, P. K. Singh, O. Prakash, and M. P. Singh, Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease. Biochim. Biophys. Acta Mol. Basis Dis. 1832, 1227 (2013).
    • (2013) Biochim. Biophys. Acta Mol. Basis Dis. , vol.1832 , pp. 1227
    • Dixit, A.1    Srivastava, G.2    Verma, D.3    Mishra, M.4    Singh, P.K.5    Prakash, O.6    Singh, M.P.7
  • 6
    • 84894369187 scopus 로고    scopus 로고
    • Does restraining nitric oxide biosynthesis rescue from toxins-induced Parkinsonism and sporadic Parkinson's disease
    • S. P. Gupta, S. Yadav, N. K. Singhal, M. N. Tiwari, S. K. Mishra, and M. P. Singh, Does restraining nitric oxide biosynthesis rescue from toxins-induced Parkinsonism and sporadic Parkinson's disease. Mol. Neurobiol. 49, 262 (2014).
    • (2014) Mol. Neurobiol. , vol.49 , pp. 262
    • Gupta, S.P.1    Yadav, S.2    Singhal, N.K.3    Tiwari, M.N.4    Mishra, S.K.5    Singh, M.P.6
  • 7
    • 84894202546 scopus 로고    scopus 로고
    • Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models
    • E. Lorenc-Koci and A. Czarnecka, Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models. Pharmacol. Rep. 65, 1043 (2013).
    • (2013) Pharmacol. Rep. , vol.65 , pp. 1043
    • Lorenc-Koci, E.1    Czarnecka, A.2
  • 8
    • 77956209909 scopus 로고    scopus 로고
    • Effects of caffeine in Parkinson's disease: From neuroprotection to the management of motor and non-motor symptoms
    • R. D. Prediger, Effects of caffeine in Parkinson's disease: From neuroprotection to the management of motor and non-motor symptoms. J. Alzheimers Dis. 20, S205 (2010).
    • (2010) J. Alzheimers Dis. , vol.20 , pp. S205
    • Prediger, R.D.1
  • 9
    • 77956180419 scopus 로고    scopus 로고
    • Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases
    • X. Chen, O. Ghribi, and J. D. Geiger, Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J. Alzheimers Dis. 20, S127 (2010).
    • (2010) J. Alzheimers Dis. , vol.20 , pp. S127
    • Chen, X.1    Ghribi, O.2    Geiger, J.D.3
  • 10
    • 0035690443 scopus 로고    scopus 로고
    • Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease
    • G. W. Ross and H. Petrovitch, Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease. Drugs Aging 18, 797 (2001).
    • (2001) Drugs Aging , vol.18 , pp. 797
    • Ross, G.W.1    Petrovitch, H.2
  • 11
    • 0028289758 scopus 로고
    • The effect of theophylline on parkinsonian symptoms
    • J. Mally and T. Stone, The effect of theophylline on parkinsonian symptoms. J. Pharm. Pharmacol. 46, 515 (1994).
    • (1994) J. Pharm. Pharmacol. , vol.46 , pp. 515
    • Mally, J.1    Stone, T.2
  • 12
    • 52949091483 scopus 로고    scopus 로고
    • Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels
    • S. Guerreiro, D. Toulorge, E. Hirsch, M. Marien, P. Sokoloff, and P. P. Michel, Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol. Pharmacol. 74, 980 (2008).
    • (2008) Mol. Pharmacol. , vol.74 , pp. 980
    • Guerreiro, S.1    Toulorge, D.2    Hirsch, E.3    Marien, M.4    Sokoloff, P.5    Michel, P.P.6
  • 13
    • 77954541590 scopus 로고    scopus 로고
    • Caffeine attenuates lipopolysaccharide-induced neuroinflammation
    • H. M. Brothers, Y. Marchalant, and G. L. Wenk, Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci. Lett. 480, 97 (2010).
    • (2010) Neurosci. Lett. , vol.480 , pp. 97
    • Brothers, H.M.1    Marchalant, Y.2    Wenk, G.L.3
  • 14
    • 84862876684 scopus 로고    scopus 로고
    • Role of secondary mediators in caffeine-mediated neuroprotection in maneb-and paraquat-induced Parkinson's disease phenotype in the mouse
    • S. Yadav, S. P. Gupta, G. Srivastava, P. K. Srivastava, and M. P. Singh, Role of secondary mediators in caffeine-mediated neuroprotection in maneb-and paraquat-induced Parkinson's disease phenotype in the mouse. Neurochem. Res. 37, 875 (2012).
    • (2012) Neurochem. Res. , vol.37 , pp. 875
    • Yadav, S.1    Gupta, S.P.2    Srivastava, G.3    Srivastava, P.K.4    Singh, M.P.5
  • 15
    • 41949099544 scopus 로고    scopus 로고
    • Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse
    • S. Singh, K. Singh, S. Patel, D. K. Patel, C. Singh, C. Nath, and M. P. Singh, Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse. Brain Res. 1207, 193 (2008).
    • (2008) Brain Res. , vol.1207 , pp. 193
    • Singh, S.1    Singh, K.2    Patel, S.3    Patel, D.K.4    Singh, C.5    Nath, C.6    Singh, M.P.7
  • 16
    • 77952011682 scopus 로고    scopus 로고
    • Nicotine-and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism
    • K. Singh, S. Singh, N. K. Singhal, A. Sharma, D. Parmar, and M. P. Singh, Nicotine-and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism. Chem. Biol. Interact. 185, 81 (2010).
    • (2010) Chem. Biol. Interact. , vol.185 , pp. 81
    • Singh, K.1    Singh, S.2    Singhal, N.K.3    Sharma, A.4    Parmar, D.5    Singh, M.P.6
  • 18
    • 0345227300 scopus 로고    scopus 로고
    • Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration
    • C. A. Tobias, J. S. Shumsky, M. Shibata, M. H. Tuszynski, I. Fischer, A. Tessler, and M. Murray, Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. 184, 97 (2003).
    • (2003) Exp. Neurol. , vol.184 , pp. 97
    • Tobias, C.A.1    Shumsky, J.S.2    Shibata, M.3    Tuszynski, M.H.4    Fischer, I.5    Tessler, A.6    Murray, M.7
  • 19
    • 68149160611 scopus 로고    scopus 로고
    • Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury
    • M. K. Reddy and V. Labhasetwar, Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J. 23, 1384 (2009).
    • (2009) FASEB J. , vol.23 , pp. 1384
    • Reddy, M.K.1    Labhasetwar, V.2
  • 20
    • 80051788387 scopus 로고    scopus 로고
    • Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration
    • Y. M. Tsai, C. F. Chien, L. C. Lin, and T. H. Tsai, Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. Int. J. Pharm. 416, 331 (2011).
    • (2011) Int. J. Pharm. , vol.416 , pp. 331
    • Tsai, Y.M.1    Chien, C.F.2    Lin, L.C.3    Tsai, T.H.4
  • 22
  • 23
    • 54349106751 scopus 로고    scopus 로고
    • Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum
    • X. Chen, X. Lan, I. Roche, R. Liu, and J. D. Geiger, Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J. Neurochem. 107, 1147 (2008).
    • (2008) J. Neurochem. , vol.107 , pp. 1147
    • Chen, X.1    Lan, X.2    Roche, I.3    Liu, R.4    Geiger, J.D.5
  • 24
    • 82755192147 scopus 로고    scopus 로고
    • Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: Postnatal exposure enhances the susceptibility during adulthood
    • A. K. Singh, M. N. Tiwari, G. Upadhyay, D. K. Patel, D. Singh, O. Prakash, and M. P. Singh, Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol. Aging 33, 404 (2012).
    • (2012) Neurobiol. Aging , vol.33 , pp. 404
    • Singh, A.K.1    Tiwari, M.N.2    Upadhyay, G.3    Patel, D.K.4    Singh, D.5    Prakash, O.6    Singh, M.P.7
  • 25
    • 0036341564 scopus 로고    scopus 로고
    • HPLC Method for the analysis of paracetamol, caffeine and dipyrone
    • M. L. Altun, HPLC Method for the analysis of paracetamol, caffeine and dipyrone. Turk. J. Chem. 26, 521 (2002).
    • (2002) Turk. J. Chem. , vol.26 , pp. 521
    • Altun, M.L.1
  • 26
    • 84857932521 scopus 로고    scopus 로고
    • Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb-and paraquat-induced Parkinsonism in the mouse
    • G. Srivastava, A. Dixit, S. Yadav, D. K. Patel, O. Prakash, and M. P. Singh, Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb-and paraquat-induced Parkinsonism in the mouse. Free Radic. Biol. Med. 52, 1294 (2012).
    • (2012) Free Radic. Biol. Med. , vol.52 , pp. 1294
    • Srivastava, G.1    Dixit, A.2    Yadav, S.3    Patel, D.K.4    Prakash, O.5    Singh, M.P.6
  • 27
    • 77955550457 scopus 로고    scopus 로고
    • Involvement of nitric oxide in maneb-and paraquat-induced Parkinson's disease phenotype in mouse: Is there any link with lipid peroxidation
    • S. P. Gupta, S. Patel, S. Yadav, A. K. Singh, S. Singh, and M. P. Singh, Involvement of nitric oxide in maneb-and paraquat-induced Parkinson's disease phenotype in mouse: Is there any link with lipid peroxidation. Neurochem. Res. 35, 1206 (2010).
    • (2010) Neurochem. Res. , vol.35 , pp. 1206
    • Gupta, S.P.1    Patel, S.2    Yadav, S.3    Singh, A.K.4    Singh, S.5    Singh, M.P.6
  • 28
    • 79951575703 scopus 로고    scopus 로고
    • Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles
    • J. A. Kim, N. Lee, B. H. Kim, W. J. Rhee, S. Yoon, T. Hyeon, and T. H. Park, Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles. Biomaterials 32, 2871 (2011).
    • (2011) Biomaterials , vol.32 , pp. 2871
    • Kim, J.A.1    Lee, N.2    Kim, B.H.3    Rhee, W.J.4    Yoon, S.5    Hyeon, T.6    Park, T.H.7
  • 29
    • 84868349443 scopus 로고    scopus 로고
    • Control of cell adhesion and neurite outgrowth by patterned gold nanoparticles with tunable attractive or repulsive surface properties
    • S. Gilles, S. Winter, K. E. Michael, S. H. Meffert, P. Li, K. Greben, U. Simon, A. Offenhausser, and D. Mayer, Control of cell adhesion and neurite outgrowth by patterned gold nanoparticles with tunable attractive or repulsive surface properties. Small 8, 3357 (2012).
    • (2012) Small , vol.8 , pp. 3357
    • Gilles, S.1    Winter, S.2    Michael, K.E.3    Meffert, S.H.4    Li, P.5    Greben, K.6    Simon, U.7    Offenhausser, A.8    Mayer, D.9
  • 31
    • 84866872520 scopus 로고    scopus 로고
    • Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-B activation and ERK phosphorylation
    • C. H. Kang, R. G. Jayasooriya, M. G. Dilshara, Y. H. Choi, Y. K. Jeong, N. D. Kim, and G. Y. Kim, Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-B activation and ERK phosphorylation. Food Chem. Toxicol. 50, 4270 (2012).
    • (2012) Food Chem. Toxicol. , vol.50 , pp. 4270
    • Kang, C.H.1    Jayasooriya, R.G.2    Dilshara, M.G.3    Choi, Y.H.4    Jeong, Y.K.5    Kim, N.D.6    Kim, G.Y.7
  • 32
    • 39149085654 scopus 로고    scopus 로고
    • Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells
    • K. Nakaso, S. Ito, and K. Nakashima, Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432, 146 (2008).
    • (2008) Neurosci. Lett. , vol.432 , pp. 146
    • Nakaso, K.1    Ito, S.2    Nakashima, K.3
  • 33
    • 0025988085 scopus 로고
    • MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
    • M. Gerlach, P. Riederer, H. Przuntek, and M. B. Youdim, MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. 208, 273 (1991).
    • (1991) Eur. J. Pharmacol. , vol.208 , pp. 273
    • Gerlach, M.1    Riederer, P.2    Przuntek, H.3    Youdim, M.B.4
  • 34
    • 77950867025 scopus 로고    scopus 로고
    • Neuroprotection by caffeine: Time course and role of its metabolites in the MPTP model of Parkinson's disease
    • K. Xu, Y. H. Xu, J. F. Chen, and M. A. Schwarzschild, Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 167, 475 (2010).
    • (2010) Neuroscience , vol.167 , pp. 475
    • Xu, K.1    Xu, Y.H.2    Chen, J.F.3    Schwarzschild, M.A.4
  • 35
    • 0037713489 scopus 로고    scopus 로고
    • The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson's disease
    • S. Przedborski and M. Vila, The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson's disease. Ann. N. Y. Acad. Sci. 991, 189 (2003).
    • (2003) Ann. N. Y. Acad. Sci. , vol.991 , pp. 189
    • Przedborski, S.1    Vila, M.2
  • 36
    • 70449527787 scopus 로고    scopus 로고
    • Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation
    • M. Moon, H. G. Kim, L. Hwang, J. H. Seo, S. Kim, S. Hwang, S. Kim, D. Lee, H. Chung, M. S. Oh, K. T. Lee, and S. Park, Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox. Res. 15, 332 (2009).
    • (2009) Neurotox. Res. , vol.15 , pp. 332
    • Moon, M.1    Kim, H.G.2    Hwang, L.3    Seo, J.H.4    Kim, S.5    Hwang, S.6    Kim, S.7    Lee, D.8    Chung, H.9    Oh, M.S.10    Lee, K.T.11    Park, S.12
  • 37
    • 0031899172 scopus 로고    scopus 로고
    • Oxidative mechanisms in nigral cell death in Parkinson's disease
    • P. Jenner, Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13, 24 (1998).
    • (1998) Mov. Disord. , vol.13 , pp. 24
    • Jenner, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.